Event-Driven Stocks

ROCKWELL MEDICAL, INC.

RMTINasdaq

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 2 good● 4 warning● 2 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$69.3M$101.5M$83.6M$72.8M$61.9M$62.2M
Operating income−$4.7M$608,000−$6.7M−$16.8M−$30.3M−$28.4M
Net income−$5.3M−$480,000−$8.4M−$18.7M−$32.7M−$30.9M
Total assets$57.1M$59.2M$52.2M$46.6M$48.6M$77.7M
Total liabilities$20.2M$26.6M$30.9M$32.5M$46.0M$43.6M
Equity$37.0M$32.6M$21.3M$14.1M$2.5M$34.2M
EPS (diluted)$-0.15$-0.03$-0.37$-1.31$-3.83$-0.41
Shares out.34.1M29.3M12.6M94.0M93.6M69.0M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−6.8%
Net margin
−7.7%
Return on equity
−14.4%
Return on assets
−9.3%
Return on capital (ROCE)
−9.9%
Liabilities / assets
35.3%
Debt / equity
0.55×
Book value / share
$1.09
Revenue growth (YoY)
−31.8%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-18.33distress
Accruals / assets
−8.1%clean
Beneish M-Score
-2.79normal
Piotroski F-Score
3/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
35
/ 100
Profitability 0Growth 0Catalyst 33Earnings quality 67Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 2 severe● 4 warning● 2 good
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • Negative operating cash flow
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 2026491,2971.6+26.8%
Apr 30, 2026387,4481.8-60.9%
Apr 15, 2026990,6376.0+33.3%
Mar 31, 2026743,2322.2-19.0%
Mar 13, 2026917,3733.5+7.3%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)